AR230954A1 - Un metodo mejorado de separacion y concentracion de la proteina de actividad pro-coagulante viii:c a partir de un complejo de factor viii que contiene viii:c y viii:rp y un inmunoabsorbente empleado - Google Patents
Un metodo mejorado de separacion y concentracion de la proteina de actividad pro-coagulante viii:c a partir de un complejo de factor viii que contiene viii:c y viii:rp y un inmunoabsorbente empleadoInfo
- Publication number
- AR230954A1 AR230954A1 AR291580A AR29158082A AR230954A1 AR 230954 A1 AR230954 A1 AR 230954A1 AR 291580 A AR291580 A AR 291580A AR 29158082 A AR29158082 A AR 29158082A AR 230954 A1 AR230954 A1 AR 230954A1
- Authority
- AR
- Argentina
- Prior art keywords
- viii
- employee
- pro
- compact
- separation
- Prior art date
Links
- 230000002745 absorbent Effects 0.000 title 1
- 239000002250 absorbent Substances 0.000 title 1
- 229960000301 factor viii Drugs 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 230000002947 procoagulating effect Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 238000000926 separation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/813—Carrier is a saccharide
- Y10S530/814—Cellulose or derivatives thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- External Artificial Organs (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/330,105 US4361509A (en) | 1981-12-14 | 1981-12-14 | Ultrapurification of factor VIII using monoclonal antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
AR230954A1 true AR230954A1 (es) | 1984-08-31 |
Family
ID=23288328
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AR291580A AR230954A1 (es) | 1981-12-14 | 1982-12-14 | Un metodo mejorado de separacion y concentracion de la proteina de actividad pro-coagulante viii:c a partir de un complejo de factor viii que contiene viii:c y viii:rp y un inmunoabsorbente empleado |
Country Status (10)
Country | Link |
---|---|
US (1) | US4361509A (ja) |
EP (1) | EP0083483B2 (ja) |
JP (4) | JPH0723321B2 (ja) |
AR (1) | AR230954A1 (ja) |
AU (1) | AU545770B2 (ja) |
CA (1) | CA1208130A (ja) |
DE (3) | DE3278402D1 (ja) |
LU (1) | LU88333I2 (ja) |
NL (1) | NL930118I2 (ja) |
WO (1) | WO1983002114A1 (ja) |
Families Citing this family (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5582824A (en) * | 1981-10-19 | 1996-12-10 | Genentech, Inc. | Recombinant DES-CYS-TYR-CYS human immune interferon |
US4361509A (en) * | 1981-12-14 | 1982-11-30 | Scripps Clinic And Research Foundation | Ultrapurification of factor VIII using monoclonal antibodies |
ES8404858A1 (es) * | 1982-04-12 | 1984-05-16 | Hybritech Inc | Un procedimiento para la purificacion de un anticuerpo. |
US4397841A (en) * | 1982-06-28 | 1983-08-09 | Monsanto Company | Production of blood coagulation factor VIII:C |
US4614795A (en) * | 1982-08-05 | 1986-09-30 | University Of Rochester | Deglycosylated Human Factor VIII:C |
US4495175A (en) * | 1982-08-05 | 1985-01-22 | University Of Rochester | Preparation of highly purified human antihemophilic factor |
US4558005A (en) * | 1982-09-13 | 1985-12-10 | University Patents, Inc. | Monoclonal anti-erythropoietin |
US5055557A (en) * | 1983-03-04 | 1991-10-08 | Scripps Clinic & Research Foundation | Ultrapurification of factor IX and other vitamin K-dependent proteins |
US5614500A (en) * | 1983-03-04 | 1997-03-25 | The Scripps Research Institute | Compositions containing highly purified factor IX proteins prepared by immunoaffinity chromatography |
DE3485711D1 (de) * | 1983-03-04 | 1992-06-17 | Scripps Clinic Res | Immunoadsorbens und verfahren zur zurueckgewinnung von vitamin-k-abhaengigen proteinen mittels dieses adsorbens. |
US4650858A (en) * | 1983-03-21 | 1987-03-17 | Nordisk Gentofte A/S | Concentrate of the antihemophilic factor VIII and a process for producing it |
US4657894A (en) * | 1983-03-31 | 1987-04-14 | Scripps Clinic & Research Foundation | New factor VIII coagulant polypeptides |
US4649132A (en) * | 1983-03-31 | 1987-03-10 | Scripps Clinic And Research Foundation | Treatment of Factor VIII inhibitors |
CA1341506C (en) * | 1983-03-31 | 2006-06-06 | Theodore S. Zimmerman | Factor viii coagulant polypeptides and monoclonal antibodies to them |
US5362854A (en) * | 1983-03-31 | 1994-11-08 | Scripps Clinic & Research Foundation | Factor VIII coagulant polypeptides: method of making |
AT379510B (de) * | 1983-05-20 | 1986-01-27 | Immuno Ag | Verfahren zur herstellung einer faktor viii (ahf) -haeltigen praeparation |
US4681930A (en) * | 1983-09-20 | 1987-07-21 | Hoffmann-La Roche Inc. | Immune interferon and a method for its extraction and purification |
US6258938B1 (en) | 1983-10-28 | 2001-07-10 | Ne Medical Center Hospital, Inc. | Method for the purification and isolation of blood clotting proteins using conformation specific antibodies |
JPH07106156B2 (ja) * | 1983-10-28 | 1995-11-15 | ジェネティックス、インスティチュ−ト | ファクタ−▲viii▼および関連生産物の製造 |
ATE111490T1 (de) * | 1983-10-28 | 1994-09-15 | New England Medical Center Inc | Verfahren zur isolierung eines proteins aus einer dieses protein enthaltenden mischung unter verwendung eines konformationsspezifischen antikörpers. |
US4945041A (en) * | 1983-11-17 | 1990-07-31 | Board Of Regents | Monoclonal antibodies for Mycoplasma pneumoniae and use for diagnosis of pneumonia |
US4469630A (en) * | 1983-11-25 | 1984-09-04 | J. T. Baker Chemical Co. | Purification of monoclonal antibodies |
US4508709A (en) * | 1983-12-05 | 1985-04-02 | Armour Pharmaceutical Company | Process for purifying factor VIII:C |
MX9203641A (es) * | 1983-12-16 | 1992-07-01 | Genentech Inc | Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion. |
US4855238A (en) * | 1983-12-16 | 1989-08-08 | Genentech, Inc. | Recombinant gamma interferons having enhanced stability and methods therefor |
US4568488A (en) * | 1984-01-11 | 1986-02-04 | Lee Huang Sylvia | Reverse immunoaffinity chromatography purification method |
EP0432134A1 (en) * | 1984-01-12 | 1991-06-12 | Chiron Corporation | Hybridoma cell lines and monoclonal antibodies |
US7138505B1 (en) | 1984-01-12 | 2006-11-21 | Novartis Vaccines And Diagnostics, Inc. | Factor VIII:C nucleic acid molecules |
US5004804A (en) * | 1984-01-12 | 1991-04-02 | Nordisk Gentofte | Method and composition for preparation of factor VIIIC |
US5045455A (en) * | 1984-01-12 | 1991-09-03 | Chiron Corporation | Factor VIII:C cDNA cloning and expression |
US4716117A (en) * | 1984-10-26 | 1987-12-29 | Chiron Corporation | Monoclonal antibodies to factor VIIIC |
GB8403473D0 (en) * | 1984-02-09 | 1984-03-14 | Special Trustees For St Thomas | Purification of factor viii |
ZA852099B (en) * | 1984-03-26 | 1985-12-24 | Meloy Lab | Recombinant factor viii-c. |
IL74909A (en) * | 1984-04-20 | 1992-01-15 | Genentech Inc | Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein |
US4965199A (en) * | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
US5149787A (en) * | 1984-05-22 | 1992-09-22 | The Blood Center Research Foundation | Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing |
US4710381A (en) * | 1984-05-22 | 1987-12-01 | The Blood Center Of Southeastern Wisconsin | Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing |
US4604235A (en) * | 1984-05-23 | 1986-08-05 | J. T. Baker Chemical Company | Purification of monoclonal antibodies |
FI852866L (fi) * | 1984-07-27 | 1986-01-28 | Meloy Lab | Rekombinantfaktor viii-r. |
US4693985A (en) * | 1984-08-21 | 1987-09-15 | Pall Corporation | Methods of concentrating ligands and active membranes used therefor |
EP0182448A3 (en) * | 1984-08-24 | 1987-10-28 | Genetics Institute, Inc. | Production of factor viii and related products |
FR2570276B1 (fr) * | 1984-09-18 | 1987-09-04 | Immunotech Sa | Procede d'obtention du complexe fviii/vwf a usage therapeutique et produits en resultant |
DK525384D0 (da) * | 1984-11-05 | 1984-11-05 | Nordisk Insulinlab | Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat |
US4560504A (en) * | 1984-12-06 | 1985-12-24 | Uop Inc. | Carboxyl anchored immobilized antibodies |
US4933280A (en) * | 1984-12-11 | 1990-06-12 | California Biotechnology Inc. | Recombinant DNA sequence encoding Alveolar Surfactant Protein |
SE8501050D0 (sv) * | 1985-03-05 | 1985-03-05 | Kabivitrum Ab | Biologically active fragments of human antihemophilic factor and method for preparation thereof |
GR860984B (en) * | 1985-04-17 | 1986-08-18 | Zymogenetics Inc | Expression of factor vii and ix activities in mammalian cells |
CA1297815C (en) * | 1985-06-07 | 1992-03-24 | Barry S. Coller | Fibrinogen blocking monoclonal antibody |
GB8516570D0 (en) * | 1985-07-01 | 1985-08-07 | Common Services Agency For The | Coupling reaction |
US4758657A (en) * | 1985-07-11 | 1988-07-19 | Armour Pharmaceutical Company | Method of purifying Factor VIII:C |
GB2178533B (en) * | 1985-07-22 | 1989-07-19 | Asahi Chemical Ind | Analytical method of enzyme precursors and device therefor |
DE3707213A1 (de) * | 1987-03-06 | 1988-09-15 | Behringwerke Ag | Verfahren zur herstellung von faktor viii:c-mangelplasma und ein so erhaltenes mangelplasma |
CA1339946C (en) * | 1987-03-31 | 1998-07-07 | Michael J. Griffith | Ultrapurification process for polypeptides |
US5043429B1 (en) * | 1987-05-01 | 1997-10-14 | Scripps Research Inst | Protein fragments containing factor VIII binding domain of von willebrand factor |
US4774323A (en) * | 1987-06-29 | 1988-09-27 | Rorer Pharmaceutical Corporation | Purification of von Willebrand Factor solutions using gel permeation chromatography |
US4831118A (en) * | 1987-08-07 | 1989-05-16 | Scripps Clinic And Research Foundation | Flouroplastic immunoaffinity columns for purification of blood proteins |
IL88309A0 (en) * | 1987-11-17 | 1989-06-30 | Scripps Clinic Res | Peptides for use in the purification of factor viii |
EP0321835B1 (en) * | 1987-12-21 | 1994-09-28 | Miles Inc. | Gel filteration of factor VIII |
JP2761881B2 (ja) * | 1988-03-10 | 1998-06-04 | チッソ株式会社 | 抗体を固定化したアフイニテイクロマトグラフイ用担体 |
FR2632309B1 (fr) * | 1988-06-07 | 1990-08-24 | Lille Transfusion Sanguine | Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus |
DE3904354A1 (de) | 1989-02-14 | 1990-08-16 | Behringwerke Ag | Pasteurisiertes, gereinigtes von willebrand-faktor-konzentrat und verfahren zu seiner herstellung |
FR2644064B1 (fr) * | 1989-02-17 | 1994-05-27 | Aquitaine Dev Transf Sanguine | Procede de fabrication du facteur antihemophilique fviiic ayant une tres haute purete et facteur antihemophilique fviiic ainsi obtenu, ainsi que composition pharmaceutique le contenant |
US5252711A (en) * | 1989-06-01 | 1993-10-12 | The Gillette Company | Monoclonal antibodies useful in deodorizing skin and antibody fragments thereof |
EP0477302B1 (en) * | 1989-06-15 | 1995-02-01 | SMITH, William I. Jr. | Apparatus for inactivating infectious agents in and resisting coagulation of biological fluids |
US5110907A (en) * | 1989-08-01 | 1992-05-05 | Alpha Therapeutic Corporation | Factor viii complex purification using heparin affinity chromatography |
DE3926034C3 (de) * | 1989-08-07 | 1996-11-21 | Behringwerke Ag | Verfahren zur Herstellung eines stabilen Faktors VIII |
FR2651437A1 (fr) * | 1989-09-05 | 1991-03-08 | Lille Transfusion Sanguine | Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total. |
IT1248723B (it) * | 1990-06-12 | 1995-01-26 | Scalvo S P A | Processo per la purificazione del fattore viii e fattore viii ottenuto con tale processo |
US5279956A (en) * | 1991-06-24 | 1994-01-18 | The Scripps Research Institute | Activated protein C polypeptides and anti-peptide antibodies, diagnostic methods and systems for inhibiting activated protein C |
US5321123A (en) * | 1991-07-02 | 1994-06-14 | The Scripps Research Institute | Protein S polypeptides and anti-peptide antibodies that inhibit protein S binding to C4B binding protein, diagnostic systems and therapeutic methods |
US5278289A (en) * | 1991-11-12 | 1994-01-11 | Johnson Alan J | Antihemophilic factor stabilization |
US5288853A (en) * | 1992-04-30 | 1994-02-22 | Alpha Therapeutic Corporation | Factor viii purification process |
GB9501040D0 (en) | 1995-01-19 | 1995-03-08 | Quadrant Holdings Cambridge | Dried composition |
AT406867B (de) * | 1997-02-27 | 2000-10-25 | Immuno Ag | Verfahren zur gewinnung von hochreinem vwf oder faktor viii/vwf-komplex |
AT405403B (de) | 1997-02-27 | 1999-08-25 | Immuno Ag | Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie |
US5994310A (en) * | 1998-09-03 | 1999-11-30 | Bayer Corporation | Peptide ligands for affinity purification of human Factor VIII |
US7112438B2 (en) | 1999-01-04 | 2006-09-26 | Dyax Corp. | Binding molecules for human factor VIII and factor VIII-like proteins |
US7879621B2 (en) * | 2003-05-08 | 2011-02-01 | Phynexus, Inc. | Open channel solid phase extraction systems and methods |
DE10246125A1 (de) * | 2002-10-01 | 2004-04-15 | Aventis Behring Gmbh | Konzentrat eines Faktor VIII:C-haltigen von-Willebrand-Faktors und das dazu gehörige Verfahren |
CN103170309B (zh) * | 2013-03-12 | 2014-10-29 | 中国农业大学 | 一种莱克多巴胺抗体免疫亲和层析柱及其应用 |
US11155635B2 (en) * | 2016-12-14 | 2021-10-26 | Pangen Biotech Inc. | Anti-coagulation factor VIII antibody and use thereof |
WO2019083319A2 (ko) | 2017-10-27 | 2019-05-02 | 주식회사 녹십자홀딩스 | 본 빌리브란트 인자(vwf)의 함량 조절이 가능한 제8인자 및 본 빌리브란트 인자를 포함하는 조성물의 제조방법 |
US10934340B2 (en) | 2018-03-21 | 2021-03-02 | Baxalta Incorporated | Separation of VWF and VWF propeptide by chromatographic methods |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3652530A (en) * | 1967-08-28 | 1972-03-28 | American Nat Red Cross | Antihemophilic factor prepared from blood plasma using polyethylene glycol |
US3631018A (en) * | 1970-05-01 | 1971-12-28 | Baxter Laboratories Inc | Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate |
US3682881A (en) * | 1970-10-02 | 1972-08-08 | Baxter Laboratories Inc | Fractionation of plasma using glycine and polyethylene glycol |
US4069216A (en) * | 1975-06-16 | 1978-01-17 | Edward Shanbrom, Inc. | Simplified methods for preparation of very high purity Factor VIII concentrate |
US4188318A (en) * | 1975-06-16 | 1980-02-12 | Edward Shanbrom | Simplified method for preparation of high yield, high purity Factor VIII concentrate |
FR2363577A1 (fr) * | 1976-09-03 | 1978-03-31 | Recherches Hematologiques | Procede simplifie pour preparer avec un rendement eleve du concentre de facteur antihemophilique pur |
US4137223A (en) * | 1977-05-16 | 1979-01-30 | Edward Shanbrom, Inc. | Method of preserving blood plasma II |
CA1074698A (en) * | 1977-12-19 | 1980-04-01 | Gail A. Rock | Method of collecting anti-hemophilic factor viii from blood and blood plasma |
US4361509A (en) * | 1981-12-14 | 1982-11-30 | Scripps Clinic And Research Foundation | Ultrapurification of factor VIII using monoclonal antibodies |
-
1981
- 1981-12-14 US US06/330,105 patent/US4361509A/en not_active Ceased
-
1982
- 1982-12-08 CA CA000417226A patent/CA1208130A/en not_active Expired
- 1982-12-10 WO PCT/US1982/001726 patent/WO1983002114A1/en unknown
- 1982-12-13 AU AU91456/82A patent/AU545770B2/en not_active Expired
- 1982-12-14 EP EP82306677A patent/EP0083483B2/en not_active Expired - Lifetime
- 1982-12-14 JP JP57217928A patent/JPH0723321B2/ja not_active Expired - Lifetime
- 1982-12-14 DE DE8282306677T patent/DE3278402D1/de not_active Expired
- 1982-12-14 AR AR291580A patent/AR230954A1/es active
- 1982-12-14 DE DE3280469T patent/DE3280469T2/de not_active Expired - Lifetime
- 1982-12-14 DE DE1993175054 patent/DE19375054I2/de active Active
-
1991
- 1991-07-18 JP JP3202313A patent/JPH0784480B2/ja not_active Expired - Lifetime
-
1993
- 1993-06-24 LU LU88333C patent/LU88333I2/fr unknown
- 1993-06-30 NL NL930118C patent/NL930118I2/nl unknown
-
1994
- 1994-10-06 JP JP6242965A patent/JP2554848B2/ja not_active Expired - Lifetime
-
1996
- 1996-05-07 JP JP8112373A patent/JPH08301787A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JPS58131918A (ja) | 1983-08-06 |
NL930118I2 (nl) | 1995-05-16 |
EP0083483B2 (en) | 1997-09-17 |
JPH0723321B2 (ja) | 1995-03-15 |
CA1208130A (en) | 1986-07-22 |
AU545770B2 (en) | 1985-08-01 |
LU88333I2 (fr) | 1994-05-04 |
CA1251152C (ja) | 1989-03-14 |
NL930118I1 (nl) | 1993-11-01 |
DE3280469D1 (de) | 1995-08-31 |
AU9145682A (en) | 1983-06-23 |
JP2554848B2 (ja) | 1996-11-20 |
JPH07238034A (ja) | 1995-09-12 |
EP0083483A1 (en) | 1983-07-13 |
JPH08301787A (ja) | 1996-11-19 |
EP0083483B1 (en) | 1988-04-27 |
JPH0616700A (ja) | 1994-01-25 |
DE3280469T2 (de) | 1996-01-04 |
DE19375054I2 (de) | 2005-05-12 |
JPH0784480B2 (ja) | 1995-09-13 |
WO1983002114A1 (en) | 1983-06-23 |
US4361509A (en) | 1982-11-30 |
DE3278402D1 (de) | 1988-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR230954A1 (es) | Un metodo mejorado de separacion y concentracion de la proteina de actividad pro-coagulante viii:c a partir de un complejo de factor viii que contiene viii:c y viii:rp y un inmunoabsorbente empleado | |
HK48996A (en) | Non-destructive optical trap for biological particles and method of doing same | |
JPS54139794A (en) | Method and composite substance for analyzing protein bond | |
DE69331340D1 (de) | Verfahren zur Bestimmung von Cyclooxygenase-1-Aktivität | |
DE3578569D1 (de) | Trennung von lymphocyten und monocyten aus blutproben. | |
IT1161915B (it) | Strumento di scirttura e metodo per la sua fabbricazione | |
DK159000C (da) | Indretning til mejetaersker til at sprede avner | |
NO172907C (no) | Fremgangsmaate for analyse av fluidums-innstroemning i oljebroenner | |
ES555261A0 (es) | Un metodo para detectar la presencia de un inhibidor de anticuerpos de factor viii humano en una muestra | |
FR2499414B1 (fr) | Production d'anticorps proteiniques humains | |
DE3872754D1 (de) | Nachweis von antikoerpern humaner immundefizienz-viren. | |
IT1199877B (it) | Assorbente igienico e procedimento per la sua fabbricazione | |
DE3378075D1 (en) | A potentiometric analysis system and method of using such system to analyse blood | |
IT1142029B (it) | Preparato cosmetico e procedimento per la sua preparazione | |
FR2556720B1 (fr) | Derives de l'amidine et tonicardiaques les contenant | |
GB8330237D0 (en) | Quantitative analysis of substances | |
ES536631A0 (es) | Metodo de separacion ciclonica de liquidos y aparato correspondiente | |
DE3787706D1 (de) | Verfahren zur quantitativen Bestimmung der Antigene und Antikörper. | |
PT87036A (pt) | Conjunto de analise para deteccao de antigenes de hepatite e de anticorpos de sida | |
KR860005021A (ko) | HBc 항원의 정재방법 및 정제된 HBc 항원을 이용한 HBc 항체의 측정방법 | |
NO171170C (no) | Humant protein-c antistoff | |
BG92796A (bg) | Метод за откриване на антитела в кръвта,мембранна лента и мембранна батерия за провеждана на метода | |
GB2118301B (en) | Multilayer element for quantitative analysis of protein | |
DE3887124D1 (de) | VERFAHREN ZUR BESTIMMUNG VON IgM-ANTIKÖRPERN. | |
FI893333A (fi) | Menetelmä ja reagenssi vasta-aineiden määrittämiseksi |